This page was translated automatically from Turkish. Read the original

This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it.

Advances in Our Understanding of the Genomic Basis of Depression

Advances in our understanding of the genomic basis of depression

The number of genetic variants associated with major depression has increased rapidly, but translating these findings across populations and into clinical practice remains a key challenge.

The talk explores recent advances in understanding the genomic basis of major depression (MD), a moderately heritable disorder. Larger samples of European ancestry have led to a rapid increase in the number of associated variants. However, in the absence of large-scale trans-ancestry datasets, drawing inferences across populations and translating associations into usable clinical tools and more effective treatments has been difficult. The presentation reports the latest trans-ancestry genetic associations identified by the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium (PGC). It then discusses downstream analyses aimed at understanding these associations at the mechanistic level and translating them into opportunities for drug discovery and drug repurposing, alongside studies of within-ancestry and cross-ancestry genetic prediction. The talk concludes with new initiatives within and beyond the PGC to improve the representativeness of research resources and extend insights from genetics to other areas of mental health research.

All WCP 2026 summaries